Shanda Asset Management Holdings’s Acorda Therapeutics ACOR Stock Holding History

Shanda Asset Management Holdings’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-216	Closed	-$199K	–	45
2019 Q2	$199K	Hold	216	–	–	0.04%	32
2019 Q1	$345K	Hold	216	–	–	0.06%	47
2018 Q4	$404K	Hold	216	–	–	0.08%	40
2018 Q3	$510K	Hold	216	–	–	0.08%	32
2018 Q2	$745K	Hold	216	–	–	0.12%	43
2018 Q1	$614K	Hold	216	–	–	0.1%	34
2017 Q4	$557K	Hold	216	–	–	0.09%	37
2017 Q3	$614K	Buy	216 +133	+160%	+$350K	0.08%	32
2017 Q2	$197K	Hold	83	–	–	0.03%	31
2017 Q1	$210K	Hold	83	–	–	0.03%	32
2016 Q4	$188K	Hold	83	–	–	0.03%	26
2016 Q3	$209K	Buy	+83	New	+$248K	0.03%	23

Other funds holding ACOR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Shanda Asset Management Holdings's ACOR Position: Q3 2019 in Review

Shanda Asset Management Holdings sold out of Acorda Therapeutics (ACOR) in Q3 2019, closing a stake of 216 shares — an estimated $199K sold.

Shanda Asset Management Holdings first reported a position in ACOR in Q3 2016 and held it in 12 quarters. The position peaked at $745K in Q2 2018. 151 funds tracked by Wall St. Rank hold ACOR as of Q3 2019.

Shanda Asset Management Holdings reported no remaining Acorda Therapeutics position as of Q3 2019 after selling out during the quarter.
Shanda Asset Management Holdings sold 216 Acorda Therapeutics shares in Q3 2019, an estimated $199K.
Shanda Asset Management Holdings first reported a position in Acorda Therapeutics in Q3 2016 and held it in 12 quarters.
Shanda Asset Management Holdings's Acorda Therapeutics position peaked at $745K in Q2 2018.
151 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2019.

Based on Shanda Asset Management Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.